Search research articles
Contact Us
Filters
Showing results (1-10 of 17) with videos related to
Page
of 2
Sort By:
Expert Opinion on Drug Safety
|
April 15, 2016
Osteonecrosis of jaw beyond antiresorptive (bone-targeted) agents: new horizons in oncology
Vittorio Fusco, Daniele Santini, Grazia Armento, et al.
Expert Opinion on Drug Safety
|
May 28, 2016
Drug-induced hepatotoxicity in cancer patients - implication for treatment
Bruno Vincenzi, Grazia Armento, Mariella Spalato Ceruso, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
October 3, 2018
The Endogenous Lusitropic and Chronotropic Agent, B-Type Natriuretic Peptide, Limits Cardiac Troponin Release in Cancer Patients with an Early Impairment of Myocardial Relaxation Induced by Anthracyclines
Pierantonio Menna, Emanuela Salvatorelli, Grazia Armento, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
May 19, 2019
Pharmacology of Ranolazine versus Common Cardiovascular Drugs in Patients with Early Diastolic Dysfunction Induced by Anthracyclines or Nonanthracycline Chemotherapeutics: A Phase 2b Minitrial
Giorgio Minotti, Pierantonio Menna, Vito Calabrese, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
May 4, 2018
Pharmacology of Cardio-Oncology: Chronotropic and Lusitropic Effects of B-Type Natriuretic Peptide in Cancer Patients with Early Diastolic Dysfunction Induced by Anthracycline or Nonanthracycline Chemotherapy
Pierantonio Menna, Vito Calabrese, Grazia Armento, et al.
Critical Reviews in Oncology/Hematology
|
September 13, 2017
Developing drugs in cancer-related bone pain
Maurizio Lucchesi, Gaetano Lanzetta, Andrea Antonuzzo, et al.
Cancer Management and Research
|
July 8, 2021
What to Do and What Not to Do in the Management of Cancer Pain: A Physician Survey and Expert Recommendations
Paolo Bossi, Andrea Antonuzzo, Grazia Armento, et al.
Chemotherapy
|
February 12, 2018
Early Diastolic Dysfunction after Cancer Chemotherapy: Primary Endpoint Results of a Multicenter Cardio-Oncology Study
Vito Calabrese, Pierantonio Menna, Ombretta Annibali, et al.
Oncology
|
March 7, 2018
Body Mass Index as a Risk Factor for Toxicities in Patients with Advanced Soft-Tissue Sarcoma Treated with Trabectedin
Bruno Vincenzi, Giuseppe Badalamenti, Grazia Armento, et al.
Critical Reviews in Oncology/Hematology
|
June 14, 2015
Risk of pruritus in cancer patients treated with biological therapies: A systematic review and meta-analysis of clinical trials
Matteo Santoni, Alessandro Conti, Kalliopi Andrikou, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 17) with videos related to
Sort By:
Page
of 2
Expert Opinion on Drug Safety
|
April 15, 2016
Osteonecrosis of jaw beyond antiresorptive (bone-targeted) agents: new horizons in oncology
Vittorio Fusco, Daniele Santini, Grazia Armento, et al.
Expert Opinion on Drug Safety
|
May 28, 2016
Drug-induced hepatotoxicity in cancer patients - implication for treatment
Bruno Vincenzi, Grazia Armento, Mariella Spalato Ceruso, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
October 3, 2018
The Endogenous Lusitropic and Chronotropic Agent, B-Type Natriuretic Peptide, Limits Cardiac Troponin Release in Cancer Patients with an Early Impairment of Myocardial Relaxation Induced by Anthracyclines
Pierantonio Menna, Emanuela Salvatorelli, Grazia Armento, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
May 19, 2019
Pharmacology of Ranolazine versus Common Cardiovascular Drugs in Patients with Early Diastolic Dysfunction Induced by Anthracyclines or Nonanthracycline Chemotherapeutics: A Phase 2b Minitrial
Giorgio Minotti, Pierantonio Menna, Vito Calabrese, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
May 4, 2018
Pharmacology of Cardio-Oncology: Chronotropic and Lusitropic Effects of B-Type Natriuretic Peptide in Cancer Patients with Early Diastolic Dysfunction Induced by Anthracycline or Nonanthracycline Chemotherapy
Pierantonio Menna, Vito Calabrese, Grazia Armento, et al.
Critical Reviews in Oncology/Hematology
|
September 13, 2017
Developing drugs in cancer-related bone pain
Maurizio Lucchesi, Gaetano Lanzetta, Andrea Antonuzzo, et al.
Cancer Management and Research
|
July 8, 2021
What to Do and What Not to Do in the Management of Cancer Pain: A Physician Survey and Expert Recommendations
Paolo Bossi, Andrea Antonuzzo, Grazia Armento, et al.
Chemotherapy
|
February 12, 2018
Early Diastolic Dysfunction after Cancer Chemotherapy: Primary Endpoint Results of a Multicenter Cardio-Oncology Study
Vito Calabrese, Pierantonio Menna, Ombretta Annibali, et al.
Oncology
|
March 7, 2018
Body Mass Index as a Risk Factor for Toxicities in Patients with Advanced Soft-Tissue Sarcoma Treated with Trabectedin
Bruno Vincenzi, Giuseppe Badalamenti, Grazia Armento, et al.
Critical Reviews in Oncology/Hematology
|
June 14, 2015
Risk of pruritus in cancer patients treated with biological therapies: A systematic review and meta-analysis of clinical trials
Matteo Santoni, Alessandro Conti, Kalliopi Andrikou, et al.
Page
of 2